6-carboxyfluorescein has been researched along with verlukast in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de Vries, EG; Ossenkoppele, GJ; van der Kolk, DM; van Putten, WJ; Vellenga, E; Verdonck, LF; Verhoef, GE | 1 |
Dogan, AL; Faussat, AM; Legrand, O; Marie, JP; Perrot, JY | 1 |
2 other study(ies) available for 6-carboxyfluorescein and verlukast
Article | Year |
---|---|
P-glycoprotein and multidrug resistance protein activities in relation to treatment outcome in acute myeloid leukemia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Cyclosporins; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Flow Cytometry; Fluoresceins; Fluorescent Dyes; Glutathione; Humans; Leukemia, Myeloid; Male; Middle Aged; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Propionates; Quinolines; Randomized Controlled Trials as Topic; Reverse Transcriptase Polymerase Chain Reaction; Rhodamine 123; RNA, Messenger; Survival Analysis; Treatment Outcome; Tumor Cells, Cultured | 2000 |
Evaluation and comparison of MRP1 activity with three fluorescent dyes and three modulators in leukemic cell lines.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Bronchodilator Agents; Cyclosporine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Inhibitors; Fluoresceins; Fluorescent Dyes; Humans; Leukemia; Multidrug Resistance-Associated Proteins; Probenecid; Propionates; Quinolines; Rhodamine 123; Tumor Cells, Cultured | 2004 |